{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:38:50Z","timestamp":1783571930817,"version":"3.55.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008327","name":"Zhejiang University of Technology","doi-asserted-by":"publisher","award":["KYY-HX-20180348"],"award-info":[{"award-number":["KYY-HX-20180348"]}],"id":[{"id":"10.13039\/501100008327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LD22H090002"],"award-info":[{"award-number":["LD22H090002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174038"],"award-info":[{"award-number":["82174038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.gendis.2024.101437","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T13:14:42Z","timestamp":1727097282000},"page":"101437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mitochondrial DNA editing: Key to the treatment of neurodegenerative diseases"],"prefix":"10.1016","volume":"12","author":[{"given":"Ye","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7626-5922","authenticated-orcid":false,"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.gendis.2024.101437_bib1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/1873-3468.14089","article-title":"MICOS and the mitochondrial inner membrane morphology - when things get out of shape","volume":"595","author":"Mukherjee","year":"2021","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.gendis.2024.101437_bib2","doi-asserted-by":"crossref","first-page":"R395","DOI":"10.1016\/j.cub.2006.05.017","article-title":"The co-evolution of life and Earth","volume":"16","author":"Dietrich","year":"2006","journal-title":"Curr Biol"},{"key":"10.1016\/j.gendis.2024.101437_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-biochem-032620-104401","article-title":"Mitochondrial DNA release in innate immune signaling","volume":"92","author":"Newman","year":"2023","journal-title":"Annu Rev Biochem"},{"issue":"12","key":"10.1016\/j.gendis.2024.101437_bib4","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrg3275","article-title":"Human mitochondrial DNA: roles of inherited and somatic mutations","volume":"13","author":"Schon","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"19","key":"10.1016\/j.gendis.2024.101437_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911391","article-title":"Mitochondrial DNA repair in neurodegenerative diseases and ageing","volume":"23","author":"Bazzani","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1381612825666191122091320","article-title":"Neurodegenerative diseases associated with mitochondrial DNA mutations","volume":"26","author":"Zhunina","year":"2020","journal-title":"Curr Pharmaceut Des"},{"issue":"7794","key":"10.1016\/j.gendis.2024.101437_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gendis.2024.101437_bib8","first-page":"632","article-title":"Advances in mitochondrial DNA base editing technology","volume":"45","author":"Song","year":"2023","journal-title":"Yi Chuan"},{"issue":"6","key":"10.1016\/j.gendis.2024.101437_bib9","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.3390\/ijms24065798","article-title":"Mitochondrial base editing: recent advances towards therapeutic opportunities","volume":"24","author":"Kar","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5806","key":"10.1016\/j.gendis.2024.101437_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","article-title":"Sequence and organization of the human mitochondrial genome","volume":"290","author":"Anderson","year":"1981","journal-title":"Nature"},{"issue":"13\u201315","key":"10.1016\/j.gendis.2024.101437_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/ars.2021.0091","article-title":"Mitochondrial DNA instability in mammalian cells","volume":"36","author":"Carvalho","year":"2022","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.gendis.2024.101437_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-981-13-8367-0_13","article-title":"Mitochondrial genetics","volume":"1158","author":"Gon\u00e7alves","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.gendis.2024.101437_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/cells8040379","article-title":"Mitochondrial DNA: distribution, mutations, and elimination","volume":"8","author":"Yan","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.gendis.2024.101437_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/ijms22020586","article-title":"Mitochondrial structure and bioenergetics in normal and disease conditions","volume":"22","author":"Protasoni","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.gendis.2024.101437_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/joim.13055","article-title":"DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases","volume":"287","author":"Zekonyte","year":"2020","journal-title":"J Intern Med"},{"issue":"9","key":"10.1016\/j.gendis.2024.101437_bib16","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1172\/JCI120842","article-title":"The role of mitochondria in aging","volume":"128","author":"Jang","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gendis.2024.101437_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1326-9-16","article-title":"Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP\/Ld transgenic mouse model of Alzheimer's disease","volume":"9","author":"Kukreja","year":"2014","journal-title":"Mol Neurodegener"},{"issue":"12","key":"10.1016\/j.gendis.2024.101437_bib18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41588-018-0264-z","article-title":"Mitochondrial genetic medicine","volume":"50","author":"Wallace","year":"2018","journal-title":"Nat Genet"},{"issue":"24","key":"10.1016\/j.gendis.2024.101437_bib19","doi-asserted-by":"crossref","first-page":"9604","DOI":"10.3390\/ijms21249604","article-title":"Various aspects of a gene editing system-CRISPR-Cas9","volume":"21","author":"Janik","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.gendis.2024.101437_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tig.2017.11.001","article-title":"Mitochondrial genome engineering: the revolution may not be CRISPR-Ized","volume":"34","author":"Gammage","year":"2018","journal-title":"Trends Genet"},{"issue":"4","key":"10.1016\/j.gendis.2024.101437_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/emmm.201303672","article-title":"Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations","volume":"6","author":"Gammage","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10.1016\/j.gendis.2024.101437_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm.3261","article-title":"Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs","volume":"19","author":"Bacman","year":"2013","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.gendis.2024.101437_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00775-023-01991-6","article-title":"The past, present, and future of artificial zinc finger proteins: design strategies and chemical and biological applications","volume":"28","author":"Negi","year":"2023","journal-title":"J Biol Inorg Chem"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15871-y","article-title":"TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation","volume":"7","author":"Yahata","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.gendis.2024.101437_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-4939-7128-2_2","article-title":"Current overview of TALEN construction systems","volume":"1630","author":"Sakuma","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10.1016\/j.gendis.2024.101437_bib26","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41591-018-0166-8","article-title":"MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation","volume":"24","author":"Bacman","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.gendis.2024.101437_bib27","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-018-0165-9","article-title":"Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo","volume":"24","author":"Gammage","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41421-021-00325-7","article-title":"Precision modeling of mitochondrial disease in rats via DdCBE-mediated mtDNA editing","volume":"7","author":"Qi","year":"2021","journal-title":"Cell Discov"},{"issue":"6","key":"10.1016\/j.gendis.2024.101437_bib29","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2024.101437_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4939-1862-1_10","article-title":"Genome engineering using CRISPR-Cas9 system","volume":"1239","author":"Cong","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.gendis.2024.101437_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.gendis.2024.101437_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/305716","article-title":"Efficient mitochondrial genome editing by CRISPR\/Cas9","volume":"2015","author":"Jo","year":"2015","journal-title":"BioMed Res Int"},{"issue":"9","key":"10.1016\/j.gendis.2024.101437_bib33","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s11427-020-1819-8","article-title":"CRISPR\/Cas9-mediated mutagenesis at microhomologous regions of human mitochondrial genome","volume":"64","author":"Wang","year":"2021","journal-title":"Sci China Life Sci"},{"issue":"4","key":"10.1016\/j.gendis.2024.101437_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/acssynbio.8b00411","article-title":"Knock-in strategy for editing human and zebrafish mitochondrial DNA using Mito-CRISPR\/Cas9 system","volume":"8","author":"Bian","year":"2019","journal-title":"ACS Synth Biol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101437_bib35","article-title":"Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing","volume":"3","author":"Bi","year":"2022","journal-title":"Innovation"},{"issue":"7817","key":"10.1016\/j.gendis.2024.101437_bib36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","article-title":"A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing","volume":"583","author":"Mok","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.gendis.2024.101437_bib37","article-title":"Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing","volume":"3","author":"Chen","year":"2022","journal-title":"Innovation"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41467-022-27962-0","article-title":"Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases","volume":"13","author":"Lim","year":"2022","journal-title":"Nat Commun"},{"issue":"5\u20136","key":"10.1016\/j.gendis.2024.101437_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41434-023-00434-w","article-title":"CRISPR\/Cas9-mediated base editors and their prospects for mitochondrial genome engineering","volume":"31","author":"Eghbalsaied","year":"2024","journal-title":"Gene Ther"},{"key":"10.1016\/j.gendis.2024.101437_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.omtn.2021.11.016","article-title":"DdCBE mediates efficient and inheritable modifications in mouse mitochondrial genome","volume":"27","author":"Guo","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"10.1016\/j.gendis.2024.101437_bib41","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/s41587-022-01256-8","article-title":"CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA","volume":"40","author":"Mok","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101437_bib42","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41587-023-01791-y","article-title":"Strand-selective base editing of human mitochondrial DNA using mitoBEs","volume":"42","author":"Yi","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41467-022-28358-w","article-title":"In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue","volume":"13","author":"Silva-Pinheiro","year":"2022","journal-title":"Nat Commun"},{"issue":"7603","key":"10.1016\/j.gendis.2024.101437_bib44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"7915","key":"10.1016\/j.gendis.2024.101437_bib45","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s41586-022-04836-5","article-title":"Mitochondrial base editor induces substantial nuclear off-target mutations","volume":"606","author":"Lei","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.gendis.2024.101437_bib46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41551-022-00968-1","article-title":"A library of base editors for the precise ablation of all protein-coding genes in the mouse mitochondrial genome","volume":"7","author":"Silva-Pinheiro","year":"2023","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41421-022-00391-5","article-title":"Mitochondrial base editor DdCBE causes substantial DNA off-target editing in nuclear genome of embryos","volume":"8","author":"Wei","year":"2022","journal-title":"Cell Discov"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13059-022-02782-z","article-title":"Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases","volume":"23","author":"Lee","year":"2022","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101437_bib49","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41587-022-01486-w","article-title":"Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors","volume":"41","author":"Lee","year":"2023","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.gendis.2024.101437_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3686","article-title":"A guide to genome engineering with programmable nucleases","volume":"15","author":"Kim","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.gendis.2024.101437_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13330","article-title":"Engineering and optimising deaminase fusions for genome editing","volume":"7","author":"Yang","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cell.2023.11.035","article-title":"Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA","volume":"187","author":"Cho","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.gendis.2024.101437_bib53","article-title":"Enhanced C-to-T and A-to-G base editing in mitochondrial DNA with engineered DdCBE and TALED","volume":"11","author":"Wei","year":"2024","journal-title":"Adv Sci"},{"issue":"2","key":"10.1016\/j.gendis.2024.101437_bib54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/acsbiomaterials.1c01114","article-title":"Rational designs at the forefront of mitochondria-targeted gene delivery: recent progress and future perspectives","volume":"8","author":"Yoshinaga","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"issue":"4","key":"10.1016\/j.gendis.2024.101437_bib55","first-page":"460","article-title":"Research progress in mitochondrial gene editing technology","volume":"52","author":"Wang","year":"2023","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib56","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1038\/s41467-022-31745-y","article-title":"Base editing in human cells with monomeric DddA-TALE fusion deaminases","volume":"13","author":"Mok","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.gendis.2024.101437_bib57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcyt.2023.10.004","article-title":"Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review","volume":"26","author":"Gao","year":"2024","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.gendis.2024.101437_bib59","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.gendis.2024.101437_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007023","article-title":"Energetic costs of cellular and therapeutic control of stochastic mitochondrial DNA populations","volume":"15","author":"Hoitzing","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.gendis.2024.101437_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.618171","article-title":"Gene therapy for neurodegenerative disease: clinical potential and directions","volume":"14","author":"Zhu","year":"2021","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"10.1016\/j.gendis.2024.101437_bib62","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.3390\/cells10123460","article-title":"Unlocking the complexity of mitochondrial DNA: a key to understanding neurodegenerative disease caused by injury","volume":"10","author":"Singh","year":"2021","journal-title":"Cells"},{"issue":"7113","key":"10.1016\/j.gendis.2024.101437_bib63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.gendis.2024.101437_bib64","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.4103\/1673-5374.306066","article-title":"Promising drug targets and associated therapeutic interventions in Parkinson's disease","volume":"16","author":"Rai","year":"2021","journal-title":"Neural Regen Res"},{"issue":"18","key":"10.1016\/j.gendis.2024.101437_bib65","doi-asserted-by":"crossref","first-page":"9839","DOI":"10.3390\/ijms22189839","article-title":"Nuclear and mitochondrial genome, epigenome and gut microbiome: emerging molecular biomarkers for Parkinson's disease","volume":"22","author":"Fonseca","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2024.101437_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ajo.2019.11.001","article-title":"Association of age-related macular degeneration on Alzheimer or Parkinson disease: a retrospective cohort study","volume":"210","author":"Choi","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"9996","key":"10.1016\/j.gendis.2024.101437_bib67","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.gendis.2024.101437_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchemneu.2016.11.009","article-title":"Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model","volume":"80","author":"Yadav","year":"2017","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.gendis.2024.101437_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103815","article-title":"Comprehensive summary of mitochondrial DNA alterations in the postmortem human brain: a systematic review","volume":"76","author":"Valiente-Pallej\u00e0","year":"2022","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.gendis.2024.101437_bib70","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1038\/s41380-023-02251-4","article-title":"Mitochondrial DNA damage triggers spread of Parkinson's disease-like pathology","volume":"28","author":"Tresse","year":"2023","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.gendis.2024.101437_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105885","article-title":"Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's disease","volume":"174","author":"Puigr\u00f2s","year":"2022","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.gendis.2024.101437_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.921412","article-title":"Mitochondrial DNA variation in Parkinson's disease: analysis of \"out-of-place\" population variants as a risk factor","volume":"14","author":"M\u00fcller-Nedebock","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"10.1016\/j.gendis.2024.101437_bib73","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/biomedicines8120591","article-title":"Mitochondrial dysfunction in Parkinson's disease: focus on mitochondrial DNA","volume":"8","author":"Buneeva","year":"2020","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.gendis.2024.101437_bib74","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/1570159X20666220810114644","article-title":"mtDNA maintenance and alterations in the pathogenesis of neurodegenerative diseases","volume":"21","author":"Shang","year":"2023","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.gendis.2024.101437_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13548","article-title":"Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease","volume":"7","author":"D\u00f6lle","year":"2016","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.gendis.2024.101437_bib76","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/antiox9111159","article-title":"Dopamine therapy and the regulation of oxidative stress and mitochondrial DNA copy number in patients with Parkinson's disease","volume":"9","author":"Chen","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.gendis.2024.101437_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2013.09.034","article-title":"Twinkle mutation in an Italian family with external progressive ophthalmoplegia and Parkinsonism: a case report and an update on the state of art","volume":"556","author":"Kiferle","year":"2013","journal-title":"Neurosci Lett"},{"issue":"12","key":"10.1016\/j.gendis.2024.101437_bib78","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1001\/archneurol.2012.405","article-title":"MPV17 mutations causing adult-onset multisystemic disorder with multiple mitochondrial DNA deletions","volume":"69","author":"Garone","year":"2012","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101437_bib79","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajpath.2015.10.004","article-title":"Altered mitochondrial DNA methylation pattern in Alzheimer disease-related pathology and in Parkinson disease","volume":"186","author":"Blanch","year":"2016","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41588-023-01632-3","article-title":"Gene therapy for Parkinson's disease models","volume":"56","author":"Faial","year":"2024","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.gendis.2024.101437_bib81","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114712","article-title":"Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease","volume":"13","author":"Hwu","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"3","key":"10.1016\/j.gendis.2024.101437_bib82","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1566523220999200817164051","article-title":"Gene therapy in the management of Parkinson's disease: potential of GDNF as a promising therapeutic strategy","volume":"20","author":"Behl","year":"2020","journal-title":"Curr Gene Ther"},{"issue":"11","key":"10.1016\/j.gendis.2024.101437_bib83","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3390\/genes12111840","article-title":"Gene therapeutic approaches for the treatment of mitochondrial dysfunction in Parkinson's disease","volume":"12","author":"Prasuhn","year":"2021","journal-title":"Genes"},{"issue":"9","key":"10.1016\/j.gendis.2024.101437_bib84","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.gendis.2024.101437_bib85","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.gendis.2024.101437_bib86","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24709","article-title":"Mitochondrial DNA mutations increase in early-stage Alzheimer disease and are inconsistent with oxidative damage","volume":"80","author":"Hoekstra","year":"2016","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.gendis.2024.101437_bib87","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.neurobiolaging.2011.08.009","article-title":"Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease","volume":"33","author":"Krishnan","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.gendis.2024.101437_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.122","article-title":"The role of mitochondrial DNA mutation on neurodegenerative diseases","volume":"47","author":"Cha","year":"2015","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.1016\/j.gendis.2024.101437_bib89","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/biom11020195","article-title":"Epigenetics of Alzheimer's disease","volume":"11","author":"Nikolac Perkovic","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbrc.2019.09.094","article-title":"Altered mitochondrial DNA methylation and mitochondrial DNA copy number in an APP\/PS1 transgenic mouse model of Alzheimer disease","volume":"520","author":"Xu","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.gendis.2024.101437_bib91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: new hope for Alzheimer's disease therapeutics","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J Adv Res"},{"issue":"2","key":"10.1016\/j.gendis.2024.101437_bib92","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40120-020-00218-z","article-title":"CRISPR-Cas9: a promising genome editing therapeutic tool for Alzheimer's disease - a narrative review","volume":"9","author":"Barman","year":"2020","journal-title":"Neurol Ther"},{"issue":"2","key":"10.1016\/j.gendis.2024.101437_bib93","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JHD-210518","article-title":"Progressive mitochondrial dysfunction of striatal synapses in R6\/2 mouse model of Huntington's disease","volume":"11","author":"Petersen","year":"2022","journal-title":"J Huntingtons Dis"},{"issue":"7","key":"10.1016\/j.gendis.2024.101437_bib94","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/ene.15340","article-title":"Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort","volume":"29","author":"Petracca","year":"2022","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.gendis.2024.101437_bib95","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4103\/1673-5374.360289","article-title":"Mitochondria in Huntington's disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies","volume":"18","author":"Jurcau","year":"2023","journal-title":"Neural Regen Res"},{"issue":"8","key":"10.1016\/j.gendis.2024.101437_bib96","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/ars.2019.8004","article-title":"Mitochondrial and redox-based therapeutic strategies in Huntington's disease","volume":"34","author":"F\u00e3o","year":"2021","journal-title":"Antioxidants Redox Signal"},{"issue":"30","key":"10.1016\/j.gendis.2024.101437_bib97","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014610118","article-title":"Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington's disease","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.gendis.2024.101437_bib98","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41593-018-0075-7","article-title":"Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes","volume":"21","author":"Victor","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.gendis.2024.101437_bib99","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2015.02.004","article-title":"Selective striatal mtDNA depletion in end-stage Huntington's disease R6\/2 mice","volume":"266","author":"Hering","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1016\/j.gendis.2024.101437_bib100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-8-45","article-title":"Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease","volume":"8","author":"Quintanilla","year":"2013","journal-title":"Mol Neurodegener"},{"issue":"9","key":"10.1016\/j.gendis.2024.101437_bib101","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14737175.2020.1806061","article-title":"Is it accurate to classify ALS as a neuromuscular disorder?","volume":"20","author":"van Es","year":"2020","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.gendis.2024.101437_bib102","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13148-020-00933-2","article-title":"Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis","volume":"12","author":"Stoccoro","year":"2020","journal-title":"Clin Epigenet"},{"issue":"12","key":"10.1016\/j.gendis.2024.101437_bib103","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","article-title":"Gene therapy for ALS: a review","volume":"29","author":"Amado","year":"2021","journal-title":"Mol Ther"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224002344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224002344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:33:27Z","timestamp":1746444807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304224002344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2352304224002344"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101437","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial DNA editing: Key to the treatment of neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101437"}}